Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

108.61
Delayed Data
As of 1:00pm ET
 +1.01 / +0.94%
Today’s Change
96.18
Today|||52-Week Range
149.34
-11.23%
Year-to-Date
10 Biotech Stocks to Watch in 2018
Nov 22 / TheStreet.com - Paid Partner Content
Biotechs Trading Lower in Q4 on Macro Uncertainty, Tepid Q3
Nov 17 / Zacks.com - Paid Partner Content
Opus Point Partners Management, LLC Buys Bioverativ Inc, ACADIA Pharmaceuticals Inc, ...
Nov 17 / GuruFocus News - Paid Partner Content
Achillion (ACHN) Shares Down as J&J Announces Stake Sale
Nov 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close107.60
Today’s open107.87
Day’s range107.57 - 109.10
Volume662,475
Average volume (3 months)1,848,382
Market cap$24.0B
Dividend yield--
Data as of 1:00pm ET, 11/24/2017

Growth & Valuation

Earnings growth (last year)+162.69%
Earnings growth (this year)+22.37%
Earnings growth (next 5 years)+19.05%
Revenue growth (last year)+21.11%
P/E ratio48.5
Price/Sales9.22
Price/Book2.77

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc+0.22+0.31%
BAXBaxter International...+0.08+0.12%
INCYIncyte Corp-0.22-0.22%
VRTXVertex Pharmaceutica...-0.49-0.33%
Data as of 1:01pm ET, 11/24/2017

Financials

Next reporting dateFebruary 1, 2018
EPS forecast (this quarter)$1.27
Annual revenue (last year)$3.0B
Annual profit (last year)$399.0M
Net profit margin13.25%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ludwig N. Hantson
Executive Vice President-
Global Operations
Julie O'Neill
Corporate headquarters
New Haven, Connecticut

Forecasts